Your browser doesn't support javascript.
loading
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
Maharaj, Kamira; Powers, John J; Achille, Alex; Deng, Susan; Fonseca, Renee; Pabon-Saldana, Mibel; Quayle, Steven N; Jones, Simon S; Villagra, Alejandro; Sotomayor, Eduardo M; Sahakian, Eva; Pinilla-Ibarz, Javier.
Afiliação
  • Maharaj K; Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Powers JJ; Cancer Biology PhD Program, University of South Florida and Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Achille A; Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Deng S; Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Fonseca R; Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Pabon-Saldana M; Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Quayle SN; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Jones SS; Acetylon Pharmaceuticals, Boston, MA.
  • Villagra A; Cue Biopharma, Cambridge, MA.
  • Sotomayor EM; Cue Biopharma, Cambridge, MA.
  • Sahakian E; Regency Pharmaceuticals LLC, Waltham, MA.
  • Pinilla-Ibarz J; George Washington Cancer Center, School of Medicine and Health Sciences, George Washington University, Washington, DC; and.
Blood Adv ; 2(21): 3012-3024, 2018 11 13.
Article em En | MEDLINE | ID: mdl-30425065

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Inativação Gênica / Desacetilase 6 de Histona Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Inativação Gênica / Desacetilase 6 de Histona Idioma: En Ano de publicação: 2018 Tipo de documento: Article